CMR-Based Risk Stratification for Adverse Outcomes in Chronic Ischemic Left Ventricular Aneurysm Patients

Kairui Bo1, Hui Wang1, Feifei Zhang2

  • 1Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China (K.B., H.W., S.S., Y.G., Z.Z., S.L., L.X.).

Academic Radiology
|June 19, 2025
PubMed

Insights

Predicting major adverse cardiovascular events (MACEs) in chronic ischemic left ventricular aneurysm (LVA) is crucial. Combining clinical data with cardiac magnetic resonance (CMR) imaging, especially left atrial strain (LA-εa), improves risk prediction.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Predictive Analytics

Background:

  • Chronic ischemic left ventricular aneurysm (LVA) carries a poor prognosis.
  • Effective clinical tools for stratifying MACE risk in LVA patients are lacking.
  • Cardiac magnetic resonance (CMR) imaging offers potential for risk assessment.

Purpose of the Study:

  • To identify independent risk factors for major adverse cardiovascular events (MACEs) in patients with chronic ischemic LVA.
  • To develop a predictive model integrating clinical and CMR features.
  • To evaluate the added value of left atrial strain (LA-εa) in risk prediction.

Main Methods:

  • Retrospective analysis of 243 patients with chronic ischemic LVA from a cohort of 1825 myocardial infarction patients.
  • Univariate and multivariate Cox regression, including LASSO, to identify MACE predictors.
  • Construction of a predictive nomogram incorporating significant clinical and CMR variables.

Main Results:

  • 82 (33.7%) patients experienced MACEs over a median 2.6-year follow-up.
  • Independent predictors included age, NYHA class, LVA diameter, LGE extent, and LA-εa.
  • LA-εa significantly improved model discrimination and reclassification (p<0.001).

Conclusions:

  • A predictive model integrating clinical data and CMR biomarkers effectively identifies MACE risk in LVA.
  • Left atrial strain (LA-εa) is a significant independent predictor of adverse outcomes.
  • This model enhances risk stratification for patients with chronic ischemic LVA.
Abstract

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
30
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
53
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
44
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
35
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
60
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
129